Storia in 2 fonti

Q-Line Biotech to raise ₹214 cr via IPO on NSE Emerge

Q-Line Biotech plans to raise ₹214 crore through an IPO on NSE Emerge for working capital and loan repayment.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 mesi fa

Q-Line Biotech to raise ₹214 cr via IPO on NSE Emerge

Q-Line Biotech plans to raise ₹214 crore through an IPO on NSE Emerge for working capital and loan repayment.

originale

economictimes.indiatimes.com1 mesi fa

Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%

Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and healthcare solutions segment, saw strong…

Leggi questa versione → originale

Timeline cronologica

martedì 19 maggio 2026·thehindubusinessline.com
Q-Line Biotech to raise ₹214 cr via IPO on NSE Emerge
Q-Line Biotech plans to raise ₹214 crore through an IPO on NSE Emerge for working capital and loan repayment.
giovedì 21 maggio 2026·economictimes.indiatimes.com
Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%
Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and…